| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |